GLYX-13 10mg

GLYX-13 is a selective weak partial agonist of the glycine site of the NMDA receptor (IA ?? 25%) which is under development by Naurex as an adjunctive therapy for treatment-resistant depression.

Price Not Available 10mg GLYX-13 10mg Supplier Page

Trivial name	GLYX-13 10mg
Catalog Number	A13576-10
Alternative Name(s)	(2S)-1-[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]-N-[(2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl]pyrrolidine-2-carboxamide
Molecular Formula	C18H31N5O6
CAS#	117928-94-6
SMILES	C[C@H]([C@@H](C(=O)N1CCC[C@H]1C(=O)N2CCC[C@H]2C(=O)N[C@@H]([C@@H](C)O)C(=O)N)N)O
Size	10mg
Supplier Page	http://www.adooq.com/glyx-13.html